Prognostic factors for early mortality following allogeneic hematopoietic cell transplantation in hematologic malignancies
{{output}}
The 100 days following allogeneic hematopoietic stem cell transplantation (allo-HCT) remains a critical period despite advancements in transplant-related care. Post-transplant cyclophosphamide (PTCy) has been implemented as an effective strategy for GVHD preve... ...
